Findings from David Rimm, MD, PhD, suggest that there may be an inverse relationship between HER2 and TROP2 expression among patients with breast cancer.
Adriana Kahn, MD
Advertisement
Articles by Adriana Kahn, MD
Gathering Data to Ascertain Biomarker Specificity in HER2– Breast Cancer
Published: | Updated:
Tissue samples collected from patients with breast cancer during treatment may help explore therapy selection and predict toxicities.
Advertisement
Latest Updated Articles
Gathering Data to Ascertain Biomarker Specificity in HER2– Breast CancerPublished: December 17th 2025 | Updated: December 19th 2025
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Removes Black Box Warning for Breast Cancer and Other Indications on HRT Products
2
How Tolerable is Pembrolizumab/Paclitaxel/Bevacizumab in PROC?
3
Neoadjuvant Therapy Improves Survival in Upfront Resectable PDAC Subtype
4
Adjuvant Selpercatinib Improves EFS in Early-Stage RET+ NSCLC
5